Recombinant Mouse IL-13 Protein

(46 citations)   
  • Purity
    >97%, by SDS-PAGE under reducing conditions and visualized by silver stain
  • Endotoxin Level
    <0.01 EU per 1 μg of the protein by the LAL method.
  • Activity
    Measured in a cell proliferation assay using TF‑1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. The ED50 for this effect is 0.75‑3 ng/mL.
  • Source
    E. coli-derived Ser26-Phe131
  • Accession #
  • N-terminal Sequence
    Analysis
    Ser26
  • Predicted Molecular Mass
    11.5 kDa
  • SDS-PAGE
    9 kDa, reducing conditions
Carrier Free
What does CF mean?
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
What formulation is right for me?
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
413-ML
 
413-ML/CF
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 50 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Reconstitution Reconstitute 5 µg vials at 50 µg/mL in sterile PBS. Reconstitute 25 µg or larger vials at 100 µg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Data Images
Recombinant Mouse IL-13 (Catalog # 413‑ML) stimulates cell proliferation of the TF-1 human erythroleukemic cell line. The ED50 for this effect is 0.75-3 ng/mL.
1 μg/lane of Recombinant Mouse IL-13 was resolved with SDS-PAGE under reducing (R) conditions and visualized by silver staining, showing a single band at 9 kDa.
Background: IL-13

IL-13 is a 17 kDa immunoregulatory cytokine that plays a key role in the pathogenesis of allergic asthma and atopy. It is secreted by Th1 and Th2 CD4+ T cells, NK cells, visceral smooth muscle cells, eosinophils, mast cells, and basophils (1 - 3). IL-13 circulates as a monomer with two internal disulfide bonds that contribute to a bundled four alpha -helix configuration (4, 5). Mature mouse IL-13 shares 57%, 75%, and 58% amino acid sequence identity with human, rat, and rhesus IL-13, respectively. Despite the low homology, it exhibits cross-species activity between human, mouse, and rat (6, 7). IL-13 has diverse activities on numerous cell types (8). On macrophages, IL-13 suppresses the production of proinflammatory cytokines and other cytotoxic substances. On B cells, IL-13 induces immunoglobulin class switching to IgE, upregulates the expression of MHC class II, CD71, CD72, and CD23, and costimulates proliferation. IL-13 upregulates IL-6 while downregulating IL-1 and TNF-alpha production by fibroblasts and endothelial cells. IL-13 binds with low affinity to IL-13 R alpha 1, triggering IL-13 R alpha 1 association with IL-4 R alpha. This high affinity receptor complex also functions as the type 2 IL-4 receptor complex (9, 10). Additionally, IL-13 binds with high affinity to IL-13 R alpha 2 which is expressed intracellularly, on the cell surface, and as a soluble molecule (11 - 14). IL-13 R alpha 2 regulates the bioavailability of both IL-13 and IL-4 and is overexpressed in glioma and several bronchial pathologies (10, 15, 16). Compared to wild type IL-13, the atopy-associated R110Q variant of IL-13 elicits increased responsiveness from eosinophils that express low levels of IL-13 R alpha 2 (17).

  • References:
    1. Wills-Karp, M. (2004) Immunol. Rev. 202:175.
    2. Nakajima, H. and K. Takatsu (2007) Int. Arch. Allergy Immunol. 142:265.
    3. Brown, K.D. et al. (1989) J. Immunol. 142:679.
    4. Moy, F.J. et al. (2001) J. Mol. Biol. 310:219.
    5. Eisenmesser, E.Z. et al. (2001) J. Mol. Biol. 310:231.
    6. Ruetten, H. and C. Thiemermann (1997) Shock 8:409.
    7. Lakkis, F.G. et al. (1997) Biochem. Biophys. Res. Commun. 235:529.
    8. Wynn, T.A. (2003) Annu. Rev. Immunol. 21:425.
    9. Andrews, A.L. et al. (2002) J. Biol. Chem. 277:46073.
    10. Tabata, Y. et al. (2007) Curr. Allergy Asthma Rep. 7:338.
    11. Chiaramonte, M.G. et al. (2003) J. Exp. Med. 197:687.
    12. Daines, M.O. and G.K. Hershey (2002) J. Biol. Chem. 227:10387.
    13. Matsumura, M. et al. (2007) Biochem. Biophys. Res. Commun. 360:464.
    14. Tabata, Y. et al. (2007) J. Immunol. 177:7905.
    15. Andrews, A.L. et al. (2006) J. Allergy Clin. Immunol. 118:858.
    16. Joshi, B.H. et al. (2006) Vitam. Horm. 74:479.
    17. Andrews, A.-L. et al. (2007) J. Allergy Clin. Immunol. 120:91.
  • Long Name:
    Interleukin 13
  • Entrez Gene IDs:
    3596 (Human); 16163 (Mouse); 116553 (Rat); 574325 (Primate)
  • Alternate Names:
    ALRHMGC116789; BHR1interleukin-13; IL13; IL-13; IL-13MGC116788; interleukin 13; MGC116786; NC30; P600
Related Research Areas
Citations:

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

46 Citations: Showing 1 - 10
Filter your results:

Species
Applications
Sample Type
  1. Mitochondrial CaMKII inhibition in airway epithelium protects against allergic asthma
    Authors: SC Sebag, OM Koval, JD Paschke, CJ Winters, OA Jaffer, R Dworski, FS Sutterwala, ME Anderson, IM Grumbach
    JCI Insight, 2017;2(3):e88297.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  2. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice
    Authors: T Sezaki, Y Hirata, T Hagiwara, YI Kawamura, T Okamura, R Takanashi, K Nakano, M Tamura-Nak, LC Burkly, T Dohi
    World J. Gastroenterol., 2017;23(13):2294-2307.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  3. Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 Immunity
    Authors: T Eddens, W Elsegeiny, ML Garcia-Her, P Castillo, G Trevejo-Nu, K Serody, BT Campfield, SA Khader, K Chen, J Rangel-Mor, JK Kolls
    Cell Rep, 2017;18(13):3078-3090.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  4. IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population
    Authors: DC Nascimento, PH Melo, AR Piñeros, RG Ferreira, DF Colón, PB Donate, FV Castanheir, A Gozzi, PG Czaikoski, W Niedbala, MC Borges, DS Zamboni, FY Liew, FQ Cunha, JC Alves-Filh
    Nat Commun, 2017;8(0):14919.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  5. IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease
    JCI Insight, 2016;1(12):.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  6. Identification and Function of Fibrocytes in Skeletal Muscle Injury Repair and Muscular Dystrophy
    J. Immunol., 2016;197(12):4750-4761.
    Species: Human
    Sample Type: Whole Cells
    Application: Bioassay
  7. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization.
    Authors: Liu K, Zhao E, Ilyas G, Lalazar G, Lin Y, Haseeb M, Tanaka K, Czaja M
    Autophagy, 2015;11(2):271-84.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  8. TREM-2 promotes macrophage survival and lung disease after respiratory viral infection.
    Authors: Wu K, Byers D, Jin X, Agapov E, Alexander-Brett J, Patel A, Cella M, Gilfilan S, Colonna M, Kober D, Brett T, Holtzman M
    J Exp Med, 2015;212(5):681-97.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  9. IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury.
    Authors: Ballinger M, Newstead M, Zeng X, Bhan U, Mo X, Kunkel S, Moore B, Flavell R, Christman J, Standiford T
    J Immunol, 2015;194(4):1894-904.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  10. Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo.
    Authors: Cao Q, Wang Y, Zheng D, Sun Y, Wang C, Wang X, Lee V, Wang Y, Zheng G, Tan T, Wang Y, Alexander S, Harris D
    Kidney Int, 2014;85(4):794-806.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  11. IkappaB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm.
    Authors: Stouch A, Zaynagetdinov R, Barham W, Stinnett A, Slaughter J, Yull F, Hoffman H, Blackwell T, Prince L
    J Immunol, 2014;193(3):1184-93.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  12. Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.
    Authors: Shibata T, Habiel D, Coelho A, Kunkel S, Lukacs N, Hogaboam C
    J Immunol, 2014;192(8):3569-81.
    Species: Mouse
    Sample Type: Tissue Homogenates
    Application: Luminex standard
  13. Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses.
    Authors: Sahin E, Haubenwallner S, Kuttke M, Kollmann I, Halfmann A, Dohnal A, Chen L, Cheng P, Hoesel B, Einwallner E, Brunner J, Kral J, Schrottmaier W, Thell K, Saferding V, Bluml S, Schabbauer G
    J Immunol, 2014;193(4):1717-27.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  14. S100A8 induces IL-10 and protects against acute lung injury.
    Authors: Hiroshima Y, Hsu K, Tedla N, Chung Y, Chow S, Herbert C, Geczy C
    J Immunol, 2014;192(6):2800-11.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  15. Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease.
    Authors: Starkey M, Essilfie A, Horvat J, Kim R, Nguyen D, Beagley K, Mattes J, Foster P, Hansbro P
    Mucosal Immunol, 2013;6(3):569-79.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  16. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity.
    Authors: Palm N, Rosenstein R, Yu S, Schenten D, Florsheim E, Medzhitov R
    Immunity, 2013;39(5):976-85.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  17. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis.
    Authors: McHedlidze T, Waldner M, Zopf S, Walker J, Rankin A, Schuchmann M, Voehringer D, McKenzie A, Neurath M, Pflanz S, Wirtz S
    Immunity, 2013;39(2):357-71.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  18. 12/15-lipoxygenase expressed in non-epithelial cells causes airway epithelial injury in asthma.
    Authors: Mabalirajan U, Rehman R, Ahmad T, Kumar S, Leishangthem G, Singh S, Dinda A, Biswal S, Agrawal A, Ghosh B
    Sci Rep, 2013;3(0):1540.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  19. IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation.
    Authors: Veremeyko, Tatyana, Siddiqui, Shafiudd, Sotnikov, Ilya, Yung, Amanda, Ponomarev, Eugene D
    PLoS ONE, 2013;8(12):e81774.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  20. Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, Is crucial for murine asthma.
    Authors: Suzukawa M, Morita H, Nambu A, Arae K, Shimura E, Shibui A, Yamaguchi S, Suzukawa K, Nakanishi W, Oboki K, Kajiwara N, Ohno T, Ishii A, Korner H, Cua D, Suto H, Yoshimoto T, Iwakura Y, Yamasoba T, Ohta K, Sudo K, Saito H, Okumura K, Broide D, Matsumoto K, Nakae S
    J Immunol, 2012;189(7):3641-52.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  21. Regulation of innate CD8+ T-cell activation mediated by cytokines.
    Proc Natl Acad Sci U S A, 2012;109(25):9971-6.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  22. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus.
    Authors: Monticelli LA, Sonnenberg GF, Abt MC
    Nat. Immunol., 2011;12(11):1045-54.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  23. Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts.
    Authors: Asquith KL, Horvat JC, Kaiko GE
    PLoS Pathog., 2011;7(5):e1001339.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  24. IL-22 Is Produced by Innate Lymphoid Cells and Limits Inflammation in Allergic Airway Disease.
    Authors: Taube C, Tertilt C, Gyulveszi G, Dehzad N, Kreymborg K, Schneeweiss K, Michel E, Reuter S, Renauld JC, Arnold-Schild D, Schild H, Buhl R, Becher B
    PLoS ONE, 2011;6(7):e21799.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  25. IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin.
    Authors: Oh MH, Oh SY, Yu J
    J. Immunol., 2011;186(12):7232-42.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  26. Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
    Authors: Kayamuro H, Yoshioka Y, Abe Y, Arita S, Katayama K, Nomura T, Yoshikawa T, Kubota-Koketsu R, Ikuta K, Okamoto S, Mori Y, Kunisawa J, Kiyono H, Itoh N, Nagano K, Kamada H, Tsutsumi Y, Tsunoda S
    J. Virol., 2010;84(24):12703-12.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  27. Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease.
    Authors: Horvat JC, Starkey MR, Kim RY, Beagley KW, Preston JA, Gibson PG, Foster PS, Hansbro PM
    J. Immunol., 2010;184(8):4159-69.
    Species: N/A
    Sample Type: N/A
    Application: ELISA Standard
  28. Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation.
    Authors: Sehra S, Yao W, Nguyen ET, Ahyi AN, Tuana FM, Ahlfeld SK, Snider P, Tepper RS, Petrache I, Conway SJ, Kaplan MH
    J. Immunol., 2010;186(8):4959-66.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  29. Critical role of IL-25 in nematode infection-induced alterations in intestinal function.
    Authors: Zhao A, Urban JF, Sun R
    J. Immunol., 2010;185(0):6921-9.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  30. Breast milk immune complexes are potent inducers of oral tolerance in neonates and prevent asthma development.
    Authors: Mosconi E, Rekima A, Seitz-Polski B
    Mucosal Immunol, 2010;3(5):461-74.
    Species: N/A
    Sample Type: N/A
    Application: ELISA Standard
  31. IL-13 receptor alpha2 regulates the immune and functional response to Nippostrongylus brasiliensis infection.
    Authors: Morimoto M, Zhao A, Sun R, Stiltz J, Madden KB, Mentink-Kane M, Ramalingam T, Wynn TA, Urban JF, Shea-Donohue T
    J. Immunol., 2009;183(3):1934-9.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  32. Thymic stromal lymphopoietin is a critical mediator of IL-13-driven allergic inflammation.
    Authors: Miyata M, Nakamura Y, Shimokawa N, Ohnuma Y, Katoh R, Matsuoka S, Okumura K, Ogawa H, Masuyama K, Nakao A
    Eur. J. Immunol., 2009;39(11):3078-83.
    Species: Mouse
    Sample Type: Whole Tissue
    Application: Bioassay
  33. IL-6 is required for airway mucus production induced by inhaled fungal allergens.
    Authors: Neveu WA, Allard JB, Dienz O, Wargo MJ, Ciliberto G, Whittaker LA, Rincon M
    J. Immunol., 2009;183(3):1732-8.
    Species: N/A
    Sample Type: N/A
    Application: ELISA Standard
  34. Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: the A-549 cell bioassay.
    Authors: Miller R, Sadhukhan R, Wu C
    J. Immunol. Methods, 2008;334(1):134-41.
    Species: Human
    Sample Type: Whole Cells
    Application: Bioassay
  35. Induction of IL-33 expression and activity in central nervous system glia.
    Authors: Hudson CA, Christophi GP, Gruber RC, Wilmore JR, Lawrence DA, Massa PT
    J. Leukoc. Biol., 2008;84(3):631-43.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  36. The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development.
    Authors: Khaled WT, Read EK, Nicholson SE, Baxter FO, Brennan AJ, Came PJ, Sprigg N, McKenzie AN, Watson CJ
    Development, 2007;134(15):2739-50.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  37. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.
    Authors: Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, Leung DY
    Immunity, 2006;24(3):341-8.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  38. Obligatory role for interleukin-13 in obstructive lesion development in airway allografts.
    Authors: Lama VN, Harada H, Badri LN, Flint A, Hogaboam CM, McKenzie A, Martinez FJ, Toews GB, Moore BB, Pinsky DJ
    Am. J. Pathol., 2006;169(1):47-60.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  39. Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile.
    Authors: Wen H, Hogaboam CM, Gauldie J, Kunkel SL
    Am. J. Pathol., 2006;168(6):1940-50.
    Species: N/A
    Sample Type: N/A
    Application: ELISA Standard
  40. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
    Authors: Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA
    Immunity, 2005;23(5):479-90.
    Species: N/A
    Sample Type: N/A
    Application: ELISA Standard
  41. P-selectin mediates IL-13-induced eosinophil transmigration but not eotaxin generation in vivo: a comparative study with IL-4-elicited responses.
    Authors: Larbi KY, Dangerfield JP, Culley FJ, Marshall D, Haskard DO, Jose PJ, Williams TJ, Nourshargh S
    J. Leukoc. Biol., 2003;73(1):65-73.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  42. Dual roles of IL-4 in lung injury and fibrosis.
    Authors: Huaux F, Liu T, McGarry B, Ullenbruch M, Phan SH
    J. Immunol., 2003;170(4):2083-92.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  43. Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts.
    Authors: Jakubzick C, Choi ES, Kunkel SL, Joshi BH, Puri RK, Hogaboam CM
    Am. J. Pathol., 2003;162(5):1475-86.
    Species: Mouse
    Sample Type: Whole Cells
    Application: Bioassay
  44. IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen.
    Authors: Herrick CA, Xu L, McKenzie AN, Tigelaar RE, Bottomly K
    J. Immunol., 2003;170(5):2488-95.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  45. IFN-gamma, but not Fas, mediates reduction of allergen-induced mucous cell metaplasia by inducing apoptosis.
    Authors: Shi ZO, Fischer MJ, De Sanctis GT, Schuyler MR, Tesfaigzi Y
    J. Immunol., 2002;168(9):4764-71.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
  46. IL-13-induced Clara cell secretory protein expression in airway epithelium: role of EGFR signaling pathway.
    Authors: Kim S, Shim JJ, Burgel PR, Ueki IF, Dao-Pick T, Tam DC, Nadel JA
    Am. J. Physiol. Lung Cell Mol. Physiol., 2002;283(1):L67-75.
    Species: Mouse
    Sample Type: In Vivo
    Application: In Vivo
Expand to show all 46 Citations

Have you used Recombinant Mouse IL-13 Protein?

Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.

Order Details

  • Formulations

Contact Information

Calculators

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷
R&D Systems Guarantee

Feedback

Customer Information